Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Glioblastoma × Arginine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 2 Neoplasms 2 Head and Neck Neoplasms 2 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sexuality 1 Sexual Dysfunction, Physiological 1 Salivary Gland Neoplasms 1 Radiation Injuries 1 Protein Metabolism 1 Polycystic Ovary Syndrome 1 Neuroendocrine Tumors 1 Neoplasm Metastasis 1 Multiple Endocrine Neoplasia Type 1 1 Mucositis 1 Meningioma 1 Malnutrition 1 Glioblastoma 1 Erectile Dysfunction 1 Colorectal Neoplasms 1 Brain Neoplasms 1

Interventions

Temozolomide 352 Radiotherapy 175 Bevacizumab 138 Radiation 69 Magnetic Resonance Spectroscopy 57 Lomustine 43 pembrolizumab 36 Irinotecan 36 Carmustine 36 Surgical Procedures, Operative 33 Nivolumab 26 Carboplatin 25 Radiosurgery 23 Specimen Handling 21 Erlotinib Hydrochloride 21 Chemotherapy, Adjuvant 20 Radiotherapy, Intensity-Modulated 18 Aminolevulinic Acid 18 Drug Therapy 17 Cyclophosphamide 17 sargramostim 15 O(6)-benzylguanine 13 Radiotherapy, Conformal 12 Granulocyte-Macrophage Colony-Stimulating Factor 12 Everolimus 12 Vorinostat 11 Sunitinib 11 Cilengitide 11 temsirolimus 10 poly ICLC 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02017249 2019-09-16

ArginineGBM

Inova Health Care Services

Phase 1 Completed

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡